Firms
Theme

IRDM

Iridium Communications Inc. · NASDAQ

News

7 latest

Zacks Investment Research

Compared to Estimates, Iridium (IRDM) Q3 Earnings: A Look at Key Metrics

Iridium Communications reported Q3 2026 revenue of $245.73 million, beating the consensus estimate of $240.81 million by 2.04%, with EPS of $0.38 significantly exceeding the $0.29 estimate by 31.03%. However, the company showed mixed performance across key metrics, with commercial voice and data ARPU slightly missing estimates and subscriber equipment revenue declining 11.5% year-over-year, though hosted payload and other data service revenue surged 121.3%. The stock carries a Zacks Rank #3 (Hold) rating and has underperformed the broader market, declining 8.4% over the past month.

The Motley Fool

AST SpaceMobile vs. Rocket Lab: Which Space-Focused Stock Is a Better Buy in 2026?

AST SpaceMobile and Rocket Lab represent two different approaches to the space economy: AST focuses on satellite-based cellular broadband connecting directly to smartphones, while Rocket Lab provides launch services and spacecraft components. Both companies are unprofitable but show different paths to profitability.

The Motley Fool

18 Launches Down, 9 More to Go for Rocket Lab. But That's Not the Big Story.

Rocket Lab has completed 18 launches in 2026 and plans to reach 27 by year-end, representing a 30% increase from 2025. However, the bigger story is the company's $8 billion acquisition of Iridium Communications, which was approved by shareholders on September 24 and is expected to close by mid-2027. The acquisition will enable Rocket Lab to design, build, launch, and operate its own satellite constellations while achieving profitability and positive free cash flow.

The Motley Fool

SpaceX Isn't Rocket Lab's Biggest Threat Now -- Blue Origin Is

Blue Origin won a $700 million NASA contract to build a Mars Telecommunications Network, beating out Rocket Lab. Rocket Lab has formally protested the award to the Government Accountability Office, arguing NASA's selection process violated congressional eligibility criteria.

Mentions IRDM

The Motley Fool

Rocket Lab's Neutron Won't Launch Until 2027. Is the Stock a Buy 65% Below Its Record?

Rocket Lab delayed its Neutron rocket's first launch to 2027 from Q4 2026 due to manufacturing defects found in the first-stage propellant tank's carbon composite dome. The stock fell 10% to $53, now 65% below its May record.

The Motley Fool

AST SpaceMobile vs. Firefly Aerospace: Which Space Infrastructure Stock Is a Better Buy in 2026?

The article compares two space infrastructure companies: AST SpaceMobile, which is building a space-based cellular network for direct smartphone connectivity, and Firefly Aerospace, which provides launch vehicles and lunar landers. While AST SpaceMobile has higher growth potential with major carrier partnerships, it trades at a significantly higher valuation (269x forward P/E) with untested technology and substantial losses.

The Motley Fool

Prediction: Rocket Lab Stock Trades Above $100 Again Before 2029

Analyst predicts Rocket Lab stock will trade above $100 before 2029, requiring roughly 14% annual gains. The prediction hinges on revenue tripling to ~$3 billion by 2028 through organic growth and the Iridium acquisition, while the Neutron reusable rocket must successfully debut and fly repeatedly. Currently trading at $74, the stock faces demanding execution requirements including the rocket's first flight and deal closure in mid-2027.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $IRDM · 0 threads

Sign in to post on $IRDM

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev